Cargando…
Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
Sex differences in innate and adaptive immune responses are known, and women generally mount a stronger immune response than men. Cancer immunotherapy, represented by immune checkpoint inhibitors (ICIs), has revolutionized the treatment of cancer, and sex differences in cancer immunotherapy are just...
Autores principales: | Wang, Shixiang, Cowley, Li An, Liu, Xue-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767080/ https://www.ncbi.nlm.nih.gov/pubmed/31487832 http://dx.doi.org/10.3390/molecules24183214 |
Ejemplares similares
-
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021) -
Intervention strategies for microbial therapeutics in cancer immunotherapy
por: Gopalakrishnan, V., et al.
Publicado: (2020) -
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
por: Wang, Shixiang, et al.
Publicado: (2019) -
Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
por: Soto Chervin, C., et al.
Publicado: (2020) -
Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy
por: MacMullan, Melanie A., et al.
Publicado: (2019)